These findings reinforce the role of GLP-1RAs, and semaglutide in particular, as an important therapeutic option for patients with type 2 diabetes and established cardiovascular disease, supporting their inclusion in evidence-based guideline recommendations
Role of iron metabolism in heart failure: From iron deficiency to iron overload
You might feel more tired for a few days
Lack of Physical Activity Without movement, weight loss looks flat
Discovering the Mechanism of Action How these medicines work defines the distinct features of their effects
Yu DX, Di Giorgio FP, Yao J, Marchetto MC, Brennand K, Wright R, et al